A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

To learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer.

Trial Details

NCT ID
NCT05977998
Phase
PHASE2
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Paclitaxel
  • Dexamethasone
  • Diphenhydramine
  • Famotidine
Locations (sample)
  • Houston, Texas, United States|29.76328,-95.36327

Key Eligibility Criteria

  • Age 18 years and above. There will be no upper age restriction. Because no dosing or adverse event data are currently available on the use of intra…
  • ECOG performance status ≤ 2 (Karnofsky ≥60%). Appendices 1 and 2.
  • Cytologic or histologic proof of adenocarcinoma of the stomach or gastroesophageal junction.
  • Adequate renal, and bone marrow function:

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →